Module3 Flashcards

1
Q

Which of the following DNA-repair mechanisms is a high fidelity process to repair double stranded DNA breaks?

A

HR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

PARP is involved in repairing single stranded DNA breaks?

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Synthetic Lethality means what?

A

when 2 non-lethal genetic events occur that individually may not have a deleterious effect on the cell, but when combined can cause cell death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

In BRCA1/BRCA2 mutated cells, repair of double strand DNA breaks is forced down the error prone ________________ pathway.

A

NHEJ

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Which of the following is a proposed mechanism of action of PARP inhibitors?

A

Prevention of BER mediated single strand DNA repair via inhibition of PARP/ PARP trapping

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

According to the NCCN guidelines, patients w advanced prostate cancer should have genetic testing to detect germline or somatic mutations in which of the following genes?

A

BRCA1, BRCA2, ATM, RAD51

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Rucaparib inhibits which PARP enzymes?

A

PARP -1, -2 AND -3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What DNA repair mutations could patients in Triton2 have?

A

BRCA1, BRCA2, ATM, CHEK2, or other specified mutations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What % of patients w measurable disease and a BRCA1, or BRCA2 mutation had a confirmed radiographic response in Triton2?

A

44%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What percentage of patients w BRCA1, or BRCA2 mutation and confirmed objective response had duration of response > 6 months in Triton2?

A

56%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What were 3 common AE’s among patients w BRCA1/BRCA2 mutation in Triton2?

A

Asthenia/fatigue, nausea, anemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What DNA repair gene mutations could patients in Triton3 have?

A

Only BRCA1, BRCA2, or ATM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

In the phase 3 PROfound trial olaparib was compared to what therapy?

A

tmt of physician’s choice (abiraterone, or enzalutamide)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

In PROfound what were the median rPFS duration for olaparib and the control arm among patients w BRCA1, BRCA2, or ATM mutation?

A

7.4 months vs. 3.6 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

In PROfound, what was the confirmed ORR in the olaparib and control arms among patients w BRCA1, BRCA2, or ATM mutation and measurable disease?

A

33% vs. 2%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

In PROfound, what was the most common grade 3 adverse event observed in the olaparib arm?

A

anemia